[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.90.95. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
October 6, 1999

Direct-to-Consumer Advertising: Education or Anathema?

Author Affiliations
 

Margaret A.WinkerMD, Deputy EditorIndividualAuthorPhil B.FontanarosaMD, Interim CoeditorIndividualAuthor

JAMA. 1999;282(13):1226-1228. doi:10-1001/pubs.JAMA-ISSN-0098-7484-282-13-jbk1006

To the Editor: Mr Holmer1 makes a case in support of direct-to-consumer (DTC) advertising that puts critics on the defensive. After all, who can be against free speech and educating and empowering patients?

Holmer plays down the inflationary effect of DTC advertising, with which the costliest drugs are pitched with all the skill that the advertising budgets of pharmaceutical companies can buy. There is no corresponding lobby for less expensive drugs with lower profit potential. Instead, spin doctors take over from medical doctors and profitability supersedes the presentation of balanced information.

First Page Preview View Large
First page PDF preview
First page PDF preview
×